ArticlePLoS computational biology2025
TXSelect: A multi-task learning model to identify secretory effectors.
Article in PLoS computational biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Machine learning for the prediction of gram-negative bacterial secreted effectors: advances and challenges.Frontiers in chemistry · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Secretory effectors from pathogenic microorganisms significantly influence pathogen survival and pathogenicity by manipulating host signalling, immune responses, and metabolic processes. However, because of sequence and structural heterogeneity among bacterial effectors, accurately classifying multiple types simultaneously remains challenging. Therefore, we developed TXSelect, a multi-task learning framework that simultaneously classifies TXSE (types I, II, III, IV and VI secretory effectors) using a shared backbone network with task-specific heads. TXSelect integrates the protein embedding features of evolutionary scale modelling (ESM), particularly the N-terminal mean, with classical descriptors to effectively capture complementary information. These descriptors include distance-based residue (DR) and split amino acid composition general (SC-PseAAC-General). Rigorous evaluation identified ESM N-terminal mean + DR + SC-PseAAC as the optimal feature combination, achieving high accuracy (validation F1 = 0.867, test F1 = 0.8645) and robust generalization. Comprehensive assessments and visualization with Uniform Manifold Approximation and Projection further validated the discriminative capability and interpretability of the model. TXSelect provides an efficient computational tool for accurately classifying bacterial effectors, supporting deeper biological understanding and potential therapeutic development.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.